Aptevo Therapeutics Inc. (APVO) stock
APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.46−0.09 (-15.97%)
Close on Nov 17, 2026Market cap $830.71KP/E –Yield –
Aptevo Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Aptevo Therapeutics's price to sales ratio was 438.7× on Apr 30, 2020.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Apr 30, 2020 | 438.7× | – |
See a number that looks wrong?